Emerge Diagnostics' Seed Round

Emerge Diagnostics raised a round of funding on July 07, 2014. Investors include i2E.

Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between ac…

Articles about Emerge Diagnostics' Seed Round: